Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jun 15;32(13):2320-34.
doi: 10.1002/sim.5629. Epub 2012 Sep 21.

A Bayesian model for misclassified binary outcomes and correlated survival data with applications to breast cancer

Affiliations

A Bayesian model for misclassified binary outcomes and correlated survival data with applications to breast cancer

Sheng Luo et al. Stat Med. .

Abstract

Breast cancer patients may experience ipsilateral breast tumor relapse (IBTR) after breast conservation therapy. IBTR is classified as either true local recurrence or new ipsilateral primary tumor. The correct classification of IBTR status has significant implications in therapeutic decision-making and patient management. However, the diagnostic tests to classify IBTR are imperfect and prone to misclassification. In addition, some observed survival data (e.g., time to relapse, time from relapse to death) are strongly correlated with IBTR status. We present a Bayesian approach to model the potentially misclassified IBTR status and the correlated survival information. We conduct the inference using a Bayesian framework via Markov chain Monte Carlo simulation implemented in WinBUGS. Extensive simulation shows that the proposed method corrects biases and provides more efficient estimates for the covariate effects on the probability of IBTR and the diagnostic test accuracy. Moreover, our method provides useful subject-specific patient prognostic information. Our method is motivated by, and applied to, a dataset of 397 breast cancer patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Time plot of one patient. t1 is the time from BCT to IBTR and t2 is time from IBTR to cause-specific death or censoring
Figure 2
Figure 2
Kaplan-Meier curves displaying differences in time to relapse (left panels) and time from IBTR to death (right panels) for patients classified as having new primary tumors (NP) and true recurrences (TR) by test 1 (top panels) and test 2 (bottom panels).

Similar articles

Cited by

References

    1. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, W N. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. New England Journal of Medicine. 2002;347:1233–41. doi: 10.1056/NEJMoa022152. - DOI - PubMed
    1. Chen AM, Meric-Bernstam F, Hunt KK, Thames H, Oswald MJ, Outlaw ED, Strom EA, McNeese MD, Kuerer HM, Ross MI, et al. Breast conservation after neoadjuvant chemotherapy: the MD Anderson Cancer Center experience. Journal of Clinical Oncology. 2004;22:2303–12. doi: 10.1200/JCO.2004.09.062. - DOI - PubMed
    1. Fowble B, Solin LJ, Schultz DJ, Rubenstein J, Goodman RL. Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. International Journal of Radiation Oncology. 1990;19:833–42. doi: 10.1016/0360-3016(90)90002-2. - DOI - PubMed
    1. Rouzier R, Extra JM, Carton M, Falcou MC, Vincent-Salomon A, Fourquet A, Pouillart P, B E. Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery. Journal of Clinical Oncology. 2001;19:3828–35. - PubMed
    1. Van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, van der Schueren E, Helle PA, van Zijl K, Bartelink H. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. Journal of the National Cancer Institute. 2000;92:1143–50. doi: 10.1093/jnci/92.14.1143. - DOI - PubMed

Publication types

LinkOut - more resources